Use the search parameters below to filter talks:

Calendar
Calendar

2009 - IPITA-IXA Joint Meeting (Venice)

ISLET XENOTRANSPLANTATION 1 AND ENCAPSULATION
15 October 2009  /  11:00 - 13:15

SLM alginate 3% v/v is optimal for a subcutaneous pig isIet monolayer cellular device

Presenter: S. Veriter, Louvain, Belgium

- SLM alginate 3% v/v is optimal for a subcutaneous pig isIet monolayer cellular device

Presenter: S. Veriter, Louvain, Belgium

Combination of immunosuppressive therapy in adult porcine islet xenotransplantation into non-human primate

Presenter: K.S. Kim, Seoul, Korea

- Combination of immunosuppressive therapy in adult porcine islet xenotransplantation into non-human primate

Presenter: K.S. Kim, Seoul, Korea

Validation of human insulin, proinsulin and C-peptide elisas for analysis of non-human primate samples and sensitive analysis of changing insulin responses to glucose during deteriorating beta cell function

Presenter: B.N. Hansen, Winston Salem, USA

- Validation of human insulin, proinsulin and C-peptide elisas for analysis of non-human primate samples and sensitive analysis of changing insulin responses to glucose during deteriorating beta cell function

Presenter: B.N. Hansen, Winston Salem, USA

Comparison of single high-dose STZ with partial pancreactomy combined low-dose STZ for diabetes induction in rhesus monkeys

Presenter: X. Jin., Sichuan, China

- Comparison of single high-dose STZ with partial pancreactomy combined low-dose STZ for diabetes induction in rhesus monkeys

Presenter: X. Jin., Sichuan, China

In vivo assessment of functional beta cell mass in macaques

Presenter: B. Movahedi, Boston, USA

- In vivo assessment of functional beta cell mass in macaques

Presenter: B. Movahedi, Boston, USA

Common marmoset monkeys a new world primate model for diabetic research a comparison with human pancreatic islets

Presenter: D. Mohanasundaram, Adelaide, Australia

- Common marmoset monkeys a new world primate model for diabetic research a comparison with human pancreatic islets

Presenter: D. Mohanasundaram, Adelaide, Australia

Intramuscular transplantation of microencapsulated pancreatic islet cells in barium cross-linked ultra-high viscosity alginate

Presenter: E. Weyand, Mainz, Germany

- Intramuscular transplantation of microencapsulated pancreatic islet cells in barium cross-linked ultra-high viscosity alginate

Presenter: E. Weyand, Mainz, Germany

Life supporting xenogeneic islet transplantation with a regimen including hepatocyte growth factor in a clawn miniature swine-to-cynomologus monkey model

Presenter: K. Yamada, Kagoshima, Japan

- Life supporting xenogeneic islet transplantation with a regimen including hepatocyte growth factor in a clawn miniature swine-to-cynomologus monkey model

Presenter: K. Yamada, Kagoshima, Japan

WHICH XENOTRANSPLANTATION TRIAL SHOULD START FIRST?
15 October 2009  /  14:15 - 15:30

Kidney xenotransplantation

Presenter: K. Yamada, Boston, USA

- Kidney xenotransplantation

Presenter: K. Yamada, Boston, USA

Lung xenotransplantation

Presenter: R. Pierson, Baltimore, USA

- Lung xenotransplantation

Presenter: R. Pierson, Baltimore, USA

Liver whole organ, auxiliary or hepatocyte xenotransplantation

Presenter: B. Gridelli, Palermo, Italy

- Liver whole organ, auxiliary or hepatocyte xenotransplantation

Presenter: B. Gridelli, Palermo, Italy

ISLET XENOTRANSPLANTATION 2
15 October 2009  /  16:00 - 18:00

Enhanced prediction of porcine isIet yield and post-transplant outcome through combining quantitative histomorphometrical parameters and flow cytometry analysis

Presenter: S. M. Jin, Seoul, Korea

- Enhanced prediction of porcine isIet yield and post-transplant outcome through combining quantitative histomorphometrical parameters and flow cytometry analysis

Presenter: S. M. Jin, Seoul, Korea

Fibrin beyond the carrier for subcutaneous isIet transplantation; Superior hyperglycemia control with reduced isIet marginal mass by promoting isIet viability and local angiogenesis

Presenter: J. S. Kim, Seoul, Korea

- Fibrin beyond the carrier for subcutaneous isIet transplantation; Superior hyperglycemia control with reduced isIet marginal mass by promoting isIet viability and local angiogenesis

Presenter: J. S. Kim, Seoul, Korea

Development of a novel, rapid and accurate pre-transplant in vitro assay to determine in vivo function of transplanted isIets of Iangerhans

Presenter: A. R. Pepper, London, Canada

- Development of a novel, rapid and accurate pre-transplant in vitro assay to determine in vivo function of transplanted isIets of Iangerhans

Presenter: A. R. Pepper, London, Canada

Transgenic expression of three antioxidant enzymes protects mouse islet allografts from rejection

Presenter: T. Mysore, Melbourne, Australia

- Transgenic expression of three antioxidant enzymes protects mouse islet allografts from rejection

Presenter: T. Mysore, Melbourne, Australia

Novel approach to promote neovascularization with endothelial-like MSC-coated islet

Presenter: J. S. Kim, Seoul, Korea

- Novel approach to promote neovascularization with endothelial-like MSC-coated islet

Presenter: J. S. Kim, Seoul, Korea

Long-term normoglycemia in adult pigs following porcine neonatal islet cell cluster transplantation

Presenter: P. M. Phillips, Westmead, Australia

- Long-term normoglycemia in adult pigs following porcine neonatal islet cell cluster transplantation

Presenter: P. M. Phillips, Westmead, Australia

Characterization of the cell composition and function of isIets isolated from different ages of newborn pigs

Presenter: H. Arefanian, Edmonton, Canada

- Characterization of the cell composition and function of isIets isolated from different ages of newborn pigs

Presenter: H. Arefanian, Edmonton, Canada

COAGULATION DYSREGULATION AS A POTENTIAL BARRIER TO XENOTRANSPLANTATION
16 October 2009  /  08:00 - 09:15

Mechanism of xenograft microangiopathy

Presenter: R. Colvin, Boston, USA

- Mechanism of xenograft microangiopathy

Presenter: R. Colvin, Boston, USA

hCD39 and hTFPI: What other transgenes should be inserted in the donor pig?

Presenter: P. Cowan, Victoria, Australia

- hCD39 and hTFPI: What other transgenes should be inserted in the donor pig?

Presenter: P. Cowan, Victoria, Australia

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi